Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Marina Biotech (MRNAD)

Marina Biotech (MRNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Marina Biotech 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 USA

www.marinabio.com P: 626-964-5788

Description:

Marina Biotech, Inc., formerly known as MDRNA, Inc., is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Company's pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs in hepatocellular carcinoma and bladder cancer. Marina's goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Marina Biotech, Inc. is headquartered in Bothell, Washington.

Key Statistics

Overview:

Market Capitalization, $K 26,568
Shares Outstanding, K 9,840
Annual Sales, $ 0 K
Annual Net Income, $ -840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,170 K
60-Month Beta 0.93
% of Insider Shareholders 50.00%
% of Institutional Shareholders 0.13%

Growth:

1-Year Return 86.21%
3-Year Return -75.89%
5-Year Return -4.59%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/21/17
Earnings Per Share ttm -0.72
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year 85.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/03/17

MRNAD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -109.13%
Return-on-Assets % -44.37%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales -106.27
Price/Cash Flow N/A
Price/Book 10.75
Book Value/Share 0.25
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar